| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.42 | 0.2 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.42 | 0.1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.41 | 0.2 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.38 | 0.001 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.01 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.26 | 0.03 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.25 | 0.4 |